1. A Nationwide Analysis of Clinical Trial Participation for Common Hepato-pancreato-Biliary Malignancies Demonstrates Survival Advantages for Subsets of Trial Patients But Disparities and Infrequency of Enrollment. (2022) Authors: Elshami, M.; Hue, J.J.; Hoehn, R.S.; Rothermel, L.D.; Bajor, D.; Mohamed, A.; Selfridge, J.E.; Chavin, K.D.; Ammori, J.B.; Hardacre, J.M.; Winter, J.M.; Ocuin, L.M. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Combined Multiagent Chemotherapy and Radiotherapy Is Associated with Improved Survival Compared to Chemotherapy Alone in Patients with Non-Operatively Managed Stage II-III Pancreatic Adenocarcinoma. (2022) Authors: Sugumar, K.; Hue, J.; Hardacre, J.; Ammori, J.; Rothermel, L.; Dorth, J.; Saltzman, J.; Mohamed, A.; Selfridge, J.; Bajor, D.; Winter, J.; Ocuin, L. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗